Skip to main content
logo
Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.0052
-0.0056 (-51.85%)
At close: Sep 30, 2026

YBGJ Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.010.0100.60.11.24
Revenue Growth
-255.99%-99.43%479.84%-91.62%-8.09%
Gross Profit
0.010.01-0.210.420.050.82
Operating Income
-1.12-1.19-1.98-1.19-1.21-1.54
Net Income
-1.06-1.08-1.78-1.2-1.2-1.54
Earnings Per Share
-0.01-0.01-0.01-0.10-0.01-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.010.010.010.010.020.03
Total Debt
1.581.293.370.390.792.69
Net Cash (Debt)
-1.57-1.28-3.36-0.39-0.77-2.67
Net Cash Growth
------
Net Cash Per Share
-0.01-0.01-0.03-0.03-0.01-0.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.73-0.84-1.34-0.74-0.6-1.02
Capital Expenditures
------0.56
Free Cash Flow
-0.73-0.84-1.34-0.74-0.6-1.59
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
66.10%66.10%-69.32%50.49%65.95%
Operating Margin
-9096.87%-9614.64%-57113.60%-197.58%-1155.72%-123.99%
Pretax Margin
-9386.79%-9616.60%-57112.16%-197.64%-1155.50%-123.95%
Profit Margin
-8570.76%-8736.73%-51161.47%-197.64%-1155.50%-123.95%
FCF Margin
-5893.24%-6822.65%-38551.27%-122.21%-576.27%-127.42%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
71.74171.071196.5559.45109.1639.60